Join the club for FREE to access the whole archive and other member benefits.

Humacyte developing off-the-shelf engineered blood vessels

Scaffold is populated by patient's own blood vessels

28-Mar-2019

Key points from article :

Blood vessels created in the lab can successfully turn into living tissue.

Could offer new treatment options for patients with damaged blood vessels.

Dialysis patients have a vein and artery joined together so can connect to dialysis machine.

Some patients' veins are not strong enough so use a synthetic implant.

But implants carry a greater risk of blood clots and infections.

Researchers grew a matrix in a bioreactor using smooth muscle cells from deceased human donors.

Patients' own cells and tiny blood vessels migrate to the engineered vessels.

Plan is to create large numbers of off-the-shelf engineered blood vessels.

Study by Humacyte published in Science Translational Medicine.

Mentioned in this article:

Click on resource name for more details.

Heather Prichard

Chief Operating Officer at Humacyte.

Humacyte

Biotechnology Company for Regenerative Medicine.

Science Translational Medicine

Journal that publish papers with topics related to translational medicine

Topics mentioned on this page:
Regenerative Medicine